Mapping epitopes in equine rhinitis A virus VP1 recognized by antibodies elicited in response to infection of the natural host

References

1. Acharya R., Fry E., Stuart D., Foz G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2·9 Å resolution. Nature 337:709–716
   [Google Scholar]
2. Berinstein A., Roivainen M., Hovi T., Mason P. W., Baxt B. 1995; Antibodies to the vitronectin receptor (integrin α _V β ₃) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 69:2664–2666
   [Google Scholar]
3. Brown F. 1992; New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022–1026
   [Google Scholar]
4. Crabb B. S., Nagesha H. S., Studdert M. J. 1992; Identification of equine herpesvirus 4 glycoprotein G: a type-specific, secreted glycoprotein. Virology 190:143–154
   [Google Scholar]
5. Crabb B. S., MacPherson C. M., Reubel G. H., Browning G. F., Studdert M. J., Drummer H. E. 1995; A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 140:245–258
   [Google Scholar]
6. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., Lea S., Newman J., Stuart D. 1997; Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743–9752
   [Google Scholar]
7. Danen E. H., Aota S. I., van Kraats A. A., Yamada K. M., Ruiter D. J., van Muijen G. N. 1995; Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin α ₅ β ₁ . J Biol Chem 270:21612–21618
   [Google Scholar]
8. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
   [Google Scholar]
9. Fricks C. E., Hogle J. M. 1990; Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 64:1934–1945
   [Google Scholar]
10. Hartley C. A., Ficorilli N., Dynon K., Drummer H. E., Huang J. A., Studdert M. J. 2001; Equine rhinitis A virus: structural proteins and immune response. J Gen Virol 82:1725–1728
    [Google Scholar]
11. Jackson T. J., Sheppard D., Denyer M., Blakemore W., King A. M. Q. 2000; The epithelial integrin α _v β ₆ is a receptor for foot-and-mouth disease virus. J Virol 74:4949–4956
    [Google Scholar]
12. Lea S., Hernandez J., Blakemore W. 7 other authors 1994; The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2:123–139
    [Google Scholar]
13. Li F., Browning G. F., Studdert M. J., Crabb B. S. 1996; Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Proc Natl Acad Sci U S A 93:990–995
    [Google Scholar]
14. Luo M., Rossmann M. G., Palmenberg A. C. 1988; Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology 166:503–514
    [Google Scholar]
15. Mateu M. G. 1995; Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 38:1–24
    [Google Scholar]
16. Mateu M. G., Andreu D., Domingo E. 1995; Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120–127
    [Google Scholar]
17. Newman J. F. E., Rowlands D. J., Brown F. 1973; A physio-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol 18:171–180
    [Google Scholar]
18. Page G. S., Mosser A., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. 1988; Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol 62:1781–1794
    [Google Scholar]
19. Ping L. H., Lemon S. M. 1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 66:2208–2216
    [Google Scholar]
20. Plummer G. 1962; An equine respiratory virus with enterovirus properties. Nature 195:519–520
    [Google Scholar]
21. Plummer G. 1963; An equine respiratory enterovirus: some biological and physical properties. Arch Gesamte Virusforsch 12:694–700
    [Google Scholar]
22. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypia T. 1994; Entry of coxsackievirus A9 into host cells: specific interactions with α _v β ₃ integrin, the vitronectin receptor. Virology 203:357–365
    [Google Scholar]
23. Rueckert R. R. 2001; Picornaviridae : the viruses and their replication. In Fields Virology , 4th edn. pp  685–715 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
24. Stanway G. 1990; Structure, function and evolution of picornaviruses. J Gen Virol 71:2483–2501
    [Google Scholar]
25. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterisation of the antigenic portion of the FMDV immunizing protein. J Gen Virol 59:295–306
    [Google Scholar]
26. Studdert M. J., Gleeson L. J. 1978; Isolation and characterisation of an equine rhinovirus. Zentralbl Veterinarmed B 25:225–237
    [Google Scholar]
27. Varrasso A., Drummer H. E., Huang J. A., Stevenson R. A., Ficorilli N., Studdert M. J., Hartley C. A. 2001; Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus. J Virol 75:10550–10556
    [Google Scholar]
28. Warner S., Hartley C. A., Stevenson R. A., Ficorilli N., Varrasso A., Studdert M. J., Crabb B. S. 2001; Evidence that equine rhinitis A virus is a target of neutralizing antibodies and participates directly in receptor binding. J Virol 75:9274–9281
    [Google Scholar]
29. Wutz G., Auer H., Nowotny N., Grosse B., Skern T., Kuechler E. 1996; Equine rhinovirus serotypes 1 and 2: relationship to each other and to aphthoviruses and cardioviruses. J Gen Virol 77:1719–1730
    [Google Scholar]
30. Xie Q. C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68:1637–1647
    [Google Scholar]